Henry Schein (HSIC): insider & executive buying
Henry Schein · Health Care · ref. ETF XLV · price $90.28
In short — 1 insider bought Henry Schein over ~6 months (1 buy, total $692k, latest May 11, 26). Public Form 4 data, informative (not a performance signal).
Are Henry Schein's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$90.28+30.8% over range
Aug 28, 25low $62.03 · high $90.74Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
56% recommend buying · 9 analysts
Latest insider buys on Henry Schein
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 11, 26 | Daniel William K | Dir | 10,000 | $692k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Henry Schein's executives bought shares recently?
1 Henry Schein insider(s) bought $692k over ~6 months (latest May 11, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for HSIC?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Henry Schein? The JPI assistant answers using our backtest data.
Keep exploring Henry Schein